RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,781 | -44.5% | 37,760 | -33.7% | 0.00% | – |
| Q2 2023 | $73,435 | -13.3% | 56,926 | -11.3% | 0.00% | – |
| Q1 2023 | $84,693 | -21.3% | 64,161 | -10.6% | 0.00% | – |
| Q4 2022 | $107,663 | -57.8% | 71,775 | -66.8% | 0.00% | – |
| Q3 2022 | $255,000 | +2.0% | 216,174 | -2.3% | 0.00% | – |
| Q2 2022 | $250,000 | -62.7% | 221,362 | -1.4% | 0.00% | -100.0% |
| Q1 2022 | $671,000 | +6.5% | 224,418 | -5.6% | 0.00% | 0.0% |
| Q4 2021 | $630,000 | -24.9% | 237,627 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $839,000 | -18.0% | 231,093 | -2.0% | 0.00% | 0.0% |
| Q2 2021 | $1,023,000 | +16.8% | 235,702 | -8.0% | 0.00% | 0.0% |
| Q1 2021 | $876,000 | -3.0% | 256,231 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $903,000 | +47.3% | 257,933 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $613,000 | +31.8% | 255,259 | +0.5% | 0.00% | 0.0% |
| Q2 2020 | $465,000 | +17.4% | 254,064 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $396,000 | -29.4% | 254,064 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $561,000 | +14.5% | 262,121 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $490,000 | -27.0% | 262,121 | +2.0% | 0.00% | 0.0% |
| Q2 2019 | $671,000 | +1.5% | 257,063 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $661,000 | +9.3% | 257,063 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $605,000 | -25.9% | 262,961 | +3.4% | 0.00% | -50.0% |
| Q3 2018 | $816,000 | +14.1% | 254,221 | +0.7% | 0.00% | +100.0% |
| Q2 2018 | $715,000 | -10.1% | 252,523 | +12.4% | 0.00% | -50.0% |
| Q1 2018 | $795,000 | -12.2% | 224,715 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $905,000 | +78.5% | 233,174 | +16.8% | 0.00% | +100.0% |
| Q3 2017 | $507,000 | -15.2% | 199,667 | -8.8% | 0.00% | 0.0% |
| Q2 2017 | $598,000 | -25.5% | 218,983 | -9.8% | 0.00% | -50.0% |
| Q1 2017 | $803,000 | +63.5% | 242,683 | +17.7% | 0.00% | +100.0% |
| Q4 2016 | $491,000 | -32.0% | 206,183 | +4.8% | 0.00% | 0.0% |
| Q3 2016 | $722,000 | +66.0% | 196,683 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $435,000 | +12.1% | 195,283 | +4.6% | 0.00% | 0.0% |
| Q1 2016 | $388,000 | -21.6% | 186,718 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $495,000 | +25.0% | 163,362 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $396,000 | -23.4% | 160,484 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $517,000 | -9.3% | 160,984 | +0.9% | 0.00% | 0.0% |
| Q1 2015 | $570,000 | +55.3% | 159,564 | -1.2% | 0.00% | 0.0% |
| Q4 2014 | $367,000 | +17.6% | 161,464 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $312,000 | -46.1% | 160,773 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $579,000 | -5.4% | 159,456 | +1.1% | 0.00% | -50.0% |
| Q1 2014 | $612,000 | +36.0% | 157,756 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $450,000 | -19.9% | 157,756 | +0.6% | 0.00% | -50.0% |
| Q3 2013 | $562,000 | +10.8% | 156,856 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $507,000 | -49.7% | 151,850 | +2.4% | 0.00% | -33.3% |
| Q1 2013 | $1,007,000 | – | 148,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |